Genetic testing before serologic screening in relatives of patients with celiac disease as a cost containment method

Journal of Clinical Gastroenterology

Volumn 43, Issue 1, 2009, Pages 43-50

  Chang, Matthew ^a   Green, Peter H R ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NONE   (United States)

Author keywords

Anti tissue transglutaminase; Decision analysis; Human leukocyte antigen (HLA) typing

Indexed keywords

HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; GASTROINTESTINAL ENDOSCOPY; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICARE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY ANALYSIS; SEROLOGY;

CELIAC DISEASE; COST CONTROL; DECISION TREES; FAMILY; GENETIC TESTING; HLA-DQ ANTIGENS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MASS SCREENING; MEDICARE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TRANSGLUTAMINASES; UNITED STATES;

EID: 67651154289     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318187311d     Document Type: Article

References (44)

1. Green P, Cellier C. Celiac disease. N Engl J Med. 2007;357: 1731-1743.
2. Green P. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005;128:S74-S78. (Pubitemid 40460825)
3. Holmes G, Dunn G, Cockel R, et al. Adenocarcinoma of the upper small bowel complicating celiac disease. Gut. 1980;21: 1010-1016. (Pubitemid 11213479)
4. Collin P, Reunala T, Pukkala E, et al. Coeliac diseaseassociated disorders and survival. Gut. 1994;35:1215-1218.
5. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001;120:636-651. (Pubitemid 32171637)
6. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of Celiac Disease in At-Risk and Not-At-Risk groups in the United States. Arch Int Med. 2003;163:286-292.
7. Lankisch P, Martinez Schramm A, Petersen F, et al. Diagnostic intervals for recognizing celiac disease. Z Gastroenterol. 1996;34:473-477. (Pubitemid 26261156)
8. Collin P. Should adults be screened for celiac disease? What are the benefits and harms of screening? Gastroenterology. 2005; 128:S104-S108.
9. Greco L, Romino R, Coto I, et al. The first large population based twin study of celiac disease. Gut. 2002;50:624-628. (Pubitemid 34407487)
10. Bonamico M, Ferri M, Mariani P, et al. Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J Pediatr Gastroenterol Nutr. 2006;42: 150-154.
11. Farré C, Humbert P, Vilar P. Serological markers and HLADQ2 haploptype among first-degree relatives of celiac patients. Dig Dis Sci. 1999;44:2344-2349.
12. Dube C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128:S57-S67. (Pubitemid 40460823)
13. Goldberg D, Kryszak D, Fasano A, et al. Screening for celiac disease in family members: is follow-up testing necessary? Dig Dis Sci. 2007;52:1082-1086.
14. Niveloni S, Pedreira S, Sugai E, et al. The natural history of gluten sensitivity: report of two new celiac disease patients resulting from a long-term follow-up of nonatrophic, firstdegree relatives. Am J Gastroenterol. 2000;95:463-468. (Pubitemid 30106177)
15. Pittschieler K, Gentili L, Niederhofer H. Onset of coeliac disease: a prospective longitudinal study. Acta Paediatr. 2003; 92:1149-1152. (Pubitemid 37297093)
16. Korponay-Szabo I, Kovacs J, Lorincz M, et al. Families with multiple cases of gluten-sensitive enteropathy. Z Gastroenterol. 1998;36:553-558. (Pubitemid 28354605)
17. Högberg L, Fä lth-Magnusson K, Grodzinsky E, et al. Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gatroenterol. 2003;38:61-65.
18. Biagi F, Campanella J, Bianchi P, et al. The incidence of coeliac disease in adult first degree relatives. Dig Liver Dis. 2008;40:97-100.
19. Dolinsek J, Urlep D, Karell K, et al. The prevalence of celiac disease among family members of celiac disease patients. Wien Klin Wochenschr. 2004;116:8-12. (Pubitemid 38979921)
20. Karinen H, Kärkkäinen P, Pihlajamäki J, et al. HLA genotyping is useful in the evaluation of the risk for celiac disease in the 1st degree relatives of patients with celiac disease. Scand J Gastroenterol. 2006;41:1299-1304.
21. Louka A, Sollid L. HLA in celiac disease: unraveling the complex genetics of a complex disorder. Tissue Antigens. 2003;61: 105-117. (Pubitemid 36549597)
22. Book LZJ, Neuhausen S. Prevalance of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol. 2003;98:377-381. (Pubitemid 36232389)
23. Muennig P. Cost-effectiveness Analyses in Health: A Practical Approach. 2nd ed. San Francisco: Jossey-Bass; 2008:253.
24. Detsky A, Naglie G, Krahn M, et al. Primer on medical decision analysis: Part 1-Getting started. Med Decis Making. 1997;17:123-125. (Pubitemid 27157026)
25. Detsky A, Naglie G, Krahn M, et al. Primer on medical decision analysis: Part 2-Building a tree. Med Decis Making. 1997;17:126-135. (Pubitemid 27157027)
26. Naglie G, Krahn M, Naimark D, et al. Primer on medical decision analysis: Part 3-Estimating probabilities and utilities. Med Decis Making. 1997;17:136-141. (Pubitemid 27157028)
27. Krahn M, Naglie G, Naimark D, et al. Primer on medical decision analysis: Part 4-Analyzing the model and interpreting the results. Med Decis Making. 1997;17:142-151. (Pubitemid 27157029)
28. Hill I. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology. 2005;128:S25-S32.
29. Nemec G, Ventura A, Stefano M, et al. Looking for celiac disease: diagnostic accuracy of two rapid commercial assays. Am J Gastroenterol. 2006;101:1597-1600. (Pubitemid 43980635)
30. CPT Code/Relative Value Search [AMA website]. Available at: https://catalog.ama-assn.org/Catalog/cpt/cpt-search.jsp?checkXwho= done; Accessed November 10, 2006.
31. Medicare Reimbursement [CMS website]. Available at: www.cms.hhs.gov/ providers/pufdownload; Accessed Nov 15. 2006.
32. Prometheus Laboratories Inc. (888) 423-5227; Personal Communication. November 8, 2006.
33. Kimball Genetics Inc. (800) 320-1807; Personal communication. November 8, 2006.
34. Sollid L. Molecular basis of celiac disease. Annu Rev Immunol. 2000;18:53-81.
35. Lo W, Sano K, Lebwohl B, et al. Changing presentation of adult celiac disease. Dig Dis Sci. 2003;48:395-398. (Pubitemid 36233010)
36. Collin P, Kaukinen K. Serologic screening for coeliac disease in risk groups: is once in the lifetime enough? Dig Liver Dis. 2008;40:101-103.
37. Bourgey M, Calcagno G, Tinto N, et al. HLA related genetic risk for coeliac disease. Gut. 2007;56:1054-1059. (Pubitemid 47123232)
38. Stene L, Honeyman M, Hoffenberg E, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006;101:2333-2340. (Pubitemid 44477562)
39. Holt P. Intestinal Malabsorption in the Elderly. Dig Dis. 2007;25: 144-150.
40. Hallert C, Granno C, Grant C, et al. Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol. 1998; 33:933-938. (Pubitemid 28439309)
41. Mustalahti K, Lohiniemi S, Collin P, et al. Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract. 2002;5:105-113. (Pubitemid 34267270)
42. Lee A, Ng D, Zivin J, et al. Economic burden of a gluten-free diet. J Hum Nutr Diet. 2007;20:423-430.
43. Greco L, Mayer M, Ciccarelli G, et al. Compliance to a glutenfree diet in adolescents, or "what do 300 coeliac disease adolescents eat every day?" Ital J Gastroenterol Hepatol. 1997;29: 305-310.
44. Akobeng A, Ramanan A, Buchan I, et al. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child. 2006;91:39-43. (Pubitemid 43059171)